Shown here is Dr. Jeffrey Epstein performing a densely packed follicular unit hair grafting transplant procedure of 1600 grafts to the frontal temporal hairline with the use of ACell Matristem Regenerative Technology.
Dr. Jeffrey Epstein / FUG Hair Transplant 1600 Grafts / ACell MatriStem Technology
Subscribe
Subscribe to our e-mail newsletter to receive updates.
If they said that surgery took a doctor withn a lot of skills, a artist hand, why they leave the assistant make half of the work or even more.
In some clinics the Doctor stay a while and all the majoroty of the grafts insertion surgery is made by the assistants, according some reports on web.
i have hair, but i wanna do it!!
Strum SB, Scholz MC, McDermed JE. Oncologist. 2000;5:45-52.)
A Journal of Urology paper from the same practice documents success with finasteride in the off-therapy period for 101 men, comparing men on IADT3 (with finasteride) vs. IADT2 (without finasteride). The on-therapy period for men in the study averaged 15.8 months, considerably longer than the 6 to 9 months for men in the JHU study. However, the time off therapy, which averaged just 3.7 months — about 41% to 62% of the 6 to 9 months on therapy at JHU — averaged 15 months for the IADT2 group (about a month off for each month on), and a striking 31 months — double — for IADT3. Moreover, while the JHU group restarted therapy when the PSA rose to the 10 to 20 ng/ml range, the Scholz team restarted at a PSA of just 5.0 ng/ml for IADT2 and just 2.5 ng/ml for IADT3, far lower than the JHU trigger points. Therefore, if the Scholz team had used the much higher JHU threshold range, their time off therapy periods would have been even longer! (Scholz MC, Jennrich RI, Strum SB, et al. Urol. 2006;175:1673-8.)
As I noted, with my challenging case I have not done as well with my own IADT3, with figures closer to a month off for a month on, but I am delighted.
Regarding the overall length of success on first-line blockade (I'm not sure second line is even envisioned at JHU), JHU apparently is achieving about 6 years of success, based on their mean follow-up time of 71 months, with their version of IADT before what they consider castrate-resistant prostate cancer has developed. In sharp contrast, Dr. Scholz has stated that there are two typical outcome patterns for the IADT3 patients in his practice: either success of first-line IADT3 therapy through about 10 or 11 years, or indefinitely long success. Moreover, after first-line IADT3 has failed to control the cancer, instead of considering the patients castrate resistant, second-line IADT is used, adding a number of additional years of success to the hormonal therapy approach.
Anyone care to speculate on the chances that these researcher/physicians at JHU will even try adding finasteride or Avodart?
I sure know which approach I want, and which I recommend.
Yes, the difference between the approaches is a vast chasm!]]>
Weight Loss surgery should be banned. It is a very costly and dangerous surgery. Surgery does not CURE obesity (what causes it), it simply FORCES you not to over eat. There are severe restrictions you need to follow after this surgery, and for the rest of your life, severe complications if you don't follow to the letter, so in a way after this surgery you are on a highly restrictive diet! People need to “cure” at the source, what causes them to eat in the first place, not some surgery.
National Hair Restoration Company GreatHairTransplants Announces A Tax Deductible Hair Loss… Call (212) 644-9494
Romans says that His eternal nature and divine power are evident in creation, and men are “without excuse”. Your heart tells you I am right; your ego tells you that I cannot prove it using Greek logic.